Samsung Medison, a medical equipment company and affiliate of Samsung Electronics, has begun an agreement to acquire all the shares of Sonio SAS, a fetal ultrasound artificial intelligence (AI) software company.

医疗设备公司三星电子（Samsung Electronics）的附属公司三星医疗（Samsung Medison）已开始签署协议，收购胎儿超声波人工智能（AI）软件公司Sonio SAS的所有股份。

Sonio was established in 2020 to boost women and children’s health. The company has built IT solutions and AI assistant features for obstetrics and gynecology ultrasound that help evaluate and document ultrasound exams.

Sonio成立于2020年，旨在促进妇女和儿童的健康。该公司为妇产科超声波建立了IT解决方案和AI助手功能，帮助评估和记录超声波检查。

The FDA 510(k)-cleared AI assistant Sonio Detect uses deep learning networks for higher image quality in real-time. It also aims to improve quality of care through greater clinical accuracy.

FDA 510（k）认证的人工智能助理Sonio Detect使用深度学习网络实时获得更高的图像质量。它还旨在通过提高临床准确性来提高护理质量。

After the deal is completed, Sonio will stay an independent company headquartered in France and continue commercial growth independently. Products and services will remain compatible with all ultrasound device makers, the company said.

交易完成后，索尼奥将保留总部位于法国的独立公司，并独立继续商业增长。该公司表示，产品和服务将与所有超声波设备制造商保持兼容。

The duo hopes to combine Sonio’s AI expertise with Samsung Medison’s ultrasound systems to market breakthrough, AI-enhanced workflows and accelerate innovation in outcomes and quality of prenatal care.

这对搭档希望将Sonio的人工智能专业知识与三星Medison的超声波系统相结合，以实现市场突破，增强人工智能的工作流程，并加速产前护理结果和质量的创新。

“We have great respect and admiration for what the Sonio team has built in the area of maternal care. Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” said Yong Kwan Kim, Samsung Medison’s CEO. “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”.

三星麦迪逊首席执行官Yong Kwan Kim表示：“我们非常尊重和钦佩Sonio团队在孕产妇保健领域所做的工作。通过收购Sonio，三星麦迪逊将继续履行我们的承诺，用技术改善人们的生活质量。”。“与Sonio的合作将汇集一流的超声AI技术和报告能力，为产前超声检查带来范式转变。”。

“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides,” added Cécile Brosset, Sonio’s CEO. “We have found in Samsung Medison an amazing, trusting partner to pursue and accelerate our roadmap and mission. In addition to close collaboration with Samsung Medison, as an independent company, Sonio will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare.” .

Sonio首席执行官Cécile Brosset补充道：“三星Medison建立的全球超声波业务与Sonio的高级AI相结合，为双方创造了令人兴奋的增长机会。”。“我们在三星Medison找到了一个令人惊叹的、值得信赖的合作伙伴，可以追求并加速我们的路线图和使命。除了与三星Medison作为一家独立公司的密切合作外，Sonio还将继续在全球范围内推进医疗报告技术和诊断软件，包括医疗保健服务不足的领域。”。